Terminated PHASE3 INTERVENTIONAL 2-arm NCT02110212

Femtosecond Laser for Cataract Surgery

A Prospective, Randomized Study of Cataract Surgery With the Assistance of the OptiMedica Femtosecond Laser System Compared to Standard Surgical Procedure of Continuous Curvilinear Capsulorhexis and Ultrasonic Phacoemulsification

Sponsor: Abbott Medical Optics

Conditions Cataract

Interventions FS Laser Surgery U/S Surgery and CCC

Updated 8 times since 2017 Last updated: Jan 31, 2025 Started: Apr 30, 2011 Primary completion: Dec 31, 2011 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

FDA approval received for product, no additional study subjects required.

Other terminated trials from Abbott Medical Optics

See all terminations from Abbott Medical Optics

This PHASE3 trial investigates Cataract and is currently terminated or withdrawn. Abbott Medical Optics leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Mar 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Mar 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Optics

Data source: Abbott Medical Optics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.